Conformational flexibility within the small domain of human serine racemase.
Conformational flexibility within the small domain of human serine racemase.
复制标题
人丝氨酸消旋酶小域内的构象灵活性。
DOI：
10.1107/s2053230x20001193
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Koulouris CR
中科院分区：
文献类型：
--
作者：
Koulouris CR
Serine racemase (SR) is a pyridoxal 5′-phosphate (PLP)-containing enzyme that converts l-serine to d-serine, an endogenous co-agonist for the N-methyl-d-aspartate receptor (NMDAR) subtype of glutamate ion channels. SR regulates d-serine levels by the reversible racemization of l-serine to d-serine, as well as the catabolism of serine by α,β-elimination to produce pyruvate. The modulation of SR activity is therefore an attractive therapeutic approach to disorders associated with abnormal glutamatergic signalling since it allows an indirect modulation of NMDAR function. In the present study, a 1.89 Å resolution crystal structure of the human SR holoenzyme (including the PLP cofactor) with four subunits in the asymmetric unit is described. Comparison of this new structure with the crystal structure of human SR with malonate (PDB entry 3l6b) shows an interdomain cleft that is open in the holo structure but which disappears when the inhibitor malonate binds and is enclosed. This is owing to a shift of the small domain (residues 78–155) in human SR similar to that previously described for the rat enzyme. This domain movement is accompanied by changes within the twist of the central four-stranded β-sheet of the small domain, including changes in the φ–ψ angles of all three residues in the C-terminal β-strand (residues 149–151). In the malonate-bound structure, Ser84 (a catalytic residue) points its side chain at the malonate and is preceded by a six-residue β-strand (residues 78–83), but in the holoenzyme the β-strand is only four residues (78–81) and His82 has φ–ψ values in the α-helical region of the Ramachandran plot. These data therefore represent a crystallographic platform that enables the structure-guided design of small-molecule modulators for this important but to date undrugged target.
登录
查看更多内容
野生型人丝氨酸消旋酶新型抑制剂的设计、合成和评估。
DOI：
10.1016/j.bmcl.2017.12.021
发表时间：
2018
期刊：
Bioorg Med Chem Lett.
影响因子：
--
作者：
Takahara S;Nakagawa K;Uchiyama T;Yoshida T;Matsumoto K;Kawasumi Y;Mizuguchi M;Obita T;Watanabe Y;Hayakawa D;Gouda H;Mori H;Toyooka N.
通讯作者：
Toyooka N.
影响因子：
4.8
作者：
Fedgchin, Maggie;Trivedi, Madhukar;Singh, Jaskaran B.
通讯作者：
Singh, Jaskaran B.
人肝脏吡哆醛-5′-磷酸依赖性丝氨酸脱水酶的晶体结构
影响因子：
8
作者：
Lei Sun;M. Bartlam;Yiwei Liu;H. Pang;Z. Rao
通讯作者：
Z. Rao
一种新型丝氨酸消旋酶抑制剂可抑制体内神经元过度激活。
影响因子：
3.5
作者：
H. Mori;Ryogo Wada;Satoyuki Takahara;Y. Horino;Hironori Izumi;T. Ishimoto;Tomoyuki Yoshida;M. Mizuguchi;T. Obita;H. Gouda;S. Hirono;N. Toyooka
通讯作者：
N. Toyooka
影响因子：
3.2
作者：
Vasilescu AN;Schweinfurth N;Borgwardt S;Gass P;Lang UE;Inta D;Eckart S
通讯作者：
Eckart S